Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Streptodornase plus dimethicone to improve visualization and lesion detection in painless gastroscopy
ChiCTR2500106615Phase 4Not yet recruiting
- Sponsor
- Haiyan People's Hospital
- Start
- Jul 2025
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of streptodornase in gastric lesion, Gastric neoplasia and gastric cancer (GC) (2 arms), sponsored by Haiyan People's Hospital. Primary endpoints: Detection rate of tiny lesions, Detection rate of precancerous lesions and 2 more. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
streptodornase
03
Conditions
gastric lesionGastric neoplasiagastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR2500106615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106615.